Skip to main content
KimeraCHEMS
Display
  • C
  • N
  • O

Calculated reference model · not an experimental or batch-certified structure. All 18 atoms shown.

Model data & sources
  • Heavy atoms only; hydrogens are omitted from the reference display.
  • Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
  • Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
Formula
C16H23NO
Method
RDKit ETKDGv3 / MMFF94s calculated reference conformer
Reports
2 on file
Everything shipping from this page today came off this batch. The code is printed on your label, and one certificate covers the whole batch.

BPAP

Nootropics

Published formats

  • Dry-Fill Capsule 60ct/50mcg/3mg
  • Liquid Dropper 30mL/100mcg Per mL/3mg
What is the difference between these?
Dry-Fill Capsule
Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
Liquid Dropper
The compound already in solution, in a dropper bottle. The label gives the amount per millilitre, the bottle volume and the total.
Each label gives the amount per unit and the total, so compare the totals rather than the container size.

Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.

Pricing

Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.

Technical Specifications

Batch COA Database ↗
CAS Registry Number260550-89-8
Molecular FormulaC₁₆H₂₃NO
Molecular Weight245.36
IUPAC Designation(2R)-1-(1-benzofuran-2-yl)-N-propylpentan-2-amine
Physical FormRefer to product documentation
Storage RequirementsRefer to product documentation
Solution VehiclePEG400, DMSO
Other Names(–)-1-(Benzofuran-2-yl)-2-propylaminopentane; (–)-BPAP; R-(–)-BPAP; BFPAPn; BFPAP; (αR)-N,α-Dipropyl-2-benzofuranethanamine; FPFS-1169
Capsule Concentration50mcg x 60ct
Liquid Concentration and Solution100mcg/ml PEG400, DMSO

Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.

Research Overview

BPAP

BPAP (Benzofuranylpropylaminopentane) is a highly specialized synthetic research compound belonging to the unique class of monoaminergic activity enhancers (MAEs). Structurally related to trace amine derivatives, BPAP is extensively investigated in neurochemical research settings for its ability to modulate neurotransmitter transport mechanics. Unlike classical monoamine releasing agents, literature indicates that BPAP enhances impulse-evoked amine release without dumping baseline neurotransmitter pools directly. It serves as a vital benchmark compound in controlled laboratory models exploring ligand-receptor interactions, competitive transport inhibition, and neurotransmitter system dynamics.

Physical & Handling Properties

Property Specification
Solution Base PEG400, DMSO

Research Applications & Mechanism of Interest

In laboratory science, BPAP provides an exceptional core framework for evaluating non-classical neuromodulation pathways. Its primary mechanism of interest centers on its targeted interactions with amine transport systems in isolated testing environments.

Primary fields of investigative research include:

  • Amine Transport Dynamics: Studying how the specific configuration of the benzofuran ring and its appended propylpentan-2-amine functional group influences ligand binding behaviors at dopamine, norepinephrine, and serotonin transporters.

  • Competitive Inhibition Profiles: Utilizing the molecule in cell-free binding assays to evaluate competitive displacement against labeled compounds, mapping out transporter-ligand affinity thresholds.

  • Bimodal Concentration-Response Modeling: Researchers utilize BPAP to analyze how varying concentrations of the molecule impact baseline cellular signaling networks and neurotransmitter responsiveness in closed in vitro systems.

  • Structure-Activity Relationship (SAR) Studies: Benchmarking BPAP against legacy monoamine modulators and endogenous trace amines to track molecular footprints, structural stability, and degradation patterns.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed. Liquid formats: do not refrigerate or freeze. Cold storage may cause the solution to cloud or precipitate. If this occurs, return to room temperature and mix until clear.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.

Related Research Compounds

Further reading: BPAP research overview

Frequently Asked Research Questions

How does BPAP differ from classical stimulants like amphetamines?

While both classes influence neurotransmitter levels, amphetamines cause neurons to dump their neurotransmitter stores uncontrollably into the synapse. BPAP is a selective activity enhancer that does not cause random release; instead, it only amplifies the amount of neurotransmitter released when a neuron naturally receives an electrical impulse.

What is the significance of BPAP's bimodal concentration-response relationship?

In preclinical models, BPAP exhibits two distinct, bell-shaped curves of activity depending on the concentration range tested. This complex pharmacodynamic behavior makes it a highly valued compound for studying narrow, non-linear activation windows.

Scientific References

  1. Knoll, J., Yoneda, F., Knoll, B., Ohde, H., & Miklya, I. (1999). "(-)1-Benzofuran-2-yl)-2-propylaminopentane [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the rat brain." British Journal of Pharmacology, 128(8), 1723–1732. doi:10.1038/sj.bjp.0702995.

  2. Miklya, I., & Knoll, J. (2003). "Analysis of the effect of (-)BPAP, a selective enhancer of the impulse propagation-mediated release of catecholamines and serotonin in the brain." Life Sciences, 72(25), 2915–2921. doi:10.1016/s0024-3205(03)00197-8.

  3. Shimazu, S., Miklya, I., et al. (2003). "Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes." Life Sciences, 72(24), 2785–2792. doi:10.1016/s0024-3205(03)00191-7.

Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.

Certificates of Analysis

Currently shipping from batch KC-BPP-01.

Kimera Chems

Compounds That Survive Scrutiny

Research use only. Not for human or veterinary use.